Measurement method for fibroblast growth factor-23 by forming immunocomplexes
AssigneeCanon Medical Diagnostics Corporation
InventorsYuhei Yamaguchi, Hiromi Miyazaki, Hitoshi Ono
Life of this patent
Estimating the term…
Loading patent…
AssigneeCanon Medical Diagnostics Corporation
InventorsYuhei Yamaguchi, Hiromi Miyazaki, Hitoshi Ono
Estimating the term…
A method for measuring fibroblast growth factor-23 (hereinafter, indicated as FGF-23) in a sample, which comprises the steps of: (1) reacting in an aqueous medium, a sample and a first antibody or an antibody fragment thereof which binds to FGF-23; (2) reacting in an aqueous medium, a second antibody or an antibody fragment thereof which binds to FGF-23 with Immunocomplex 1 produced in the aforementioned step (1) to produce Immunocomplex 2 consisting of the first antibody or the antibody fragment thereof which binds to FGF-23, FGF-23, and the second antibody or the antibody fragment thereof which binds to FGF-23; and (3) measuring Immunocomplex 2 produced in the aforementioned step (2); wherein the reaction of step (1) and/or step (2) is carried out in an aqueous medium comprising a surfactant such as a polyoxyethylene alkyl ether.
A method for measuring fibroblast growth factor-23 (FGF-23) in a sample, which comprises the steps of:
Dependencies are inferred from the claim text.